KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EBIT (2016 - 2025)

Historic EBIT for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $335.9 million.

  • Incyte's EBIT rose 1139.12% to $335.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 236856.4%. This contributed to the annual value of $1.5 billion for FY2025, which is 236856.4% up from last year.
  • According to the latest figures from Q4 2025, Incyte's EBIT is $335.9 million, which was up 1139.12% from $443.5 million recorded in Q3 2025.
  • In the past 5 years, Incyte's EBIT ranged from a high of $530.3 million in Q2 2025 and a low of -$478.1 million during Q2 2024
  • Its 5-year average for EBIT is $168.1 million, with a median of $166.7 million in 2023.
  • Its EBIT has fluctuated over the past 5 years, first skyrocketed by 432001.5% in 2021, then crashed by 34673.86% in 2024.
  • Incyte's EBIT (Quarter) stood at $110.7 million in 2021, then tumbled by 36.7% to $70.1 million in 2022, then skyrocketed by 167.17% to $187.3 million in 2023, then skyrocketed by 61.0% to $301.5 million in 2024, then rose by 11.39% to $335.9 million in 2025.
  • Its EBIT stands at $335.9 million for Q4 2025, versus $443.5 million for Q3 2025 and $530.3 million for Q2 2025.